Abstract
Epigenetics is the study of heritable change other than those encoded in DNA sequence. Cytosine methylation of DNA at CpG dinucleotides is the most well-studied epigenetic phenomenon, although epigenetic changes also encompass non-DNA methylation mechanisms, such as covalent histone modifications, micro-RNA interactions, and chromatin remodeling complexes. Methylation changes, both global and gene specific, have been observed to be associated with disease, particularly in cancer.
This chapter begins with a general overview of epigenomics, and then focuses on understanding and analyzing genome-wide cytosine methylation data. There are many microarray-based techniques available to measure cytosine methylation across the genome, as well as gold-standard techniques based on sequencing bisulfite converted DNA, which is used to measure methylation in a smaller, more targeted set of loci. We have provided an overview of many of the current technologies – their advantages, limitations, and recent improvements. Regardless of which technology is used, the goal is to produce a set of methylation measurements that are highly consistent with true methylation levels of the corresponding set of CpG dinucleotides.
Identifying all loci with aberrant methylation or hypomethylation in disease, or in natural processes such as aging, requires the comparison of methylation levels across many samples. In such studies, the development of methylation-based diagnostic tools may be of interest, potentially to be used as early disease detection strategies based on a set of sentinel loci. In addition, the identification of loci with potentially reversible methylation events may result in new therapeutic options. Given the vast number of measurable sites, prioritization of candidate loci is an important and complex issue and rests on a foundation of appropriate statistical testing and summarization. Coupled with statistical estimates of importance, the genomic context of each locus measured may offer important information about the mechanisms by which epigenetic changes impact disease and allows us further refinement of candidate loci. We will conclude this chapter by identifying issues in building methylation-based models for prediction and potential directions of further statistical research in epigenetics.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Martienssen, R.D., Zaratiegui, M., and Goto, D.B. (2005) RNA interference and heterochromatin in the fission yeast Schizosaccharomyces pombe, Trends Genet 21(8), 450–456.
Klose, R.J. and Bird, A.P. (2006) Genomic DNA methylation: the mark and its mediators, Trends Biochem Sci 2, 89–97.
Jørgensen, H.F. and Bird, A. (2002) MeCP2 and other methyl-CpG binding proteins, Ment Retard Dev Disabil Res Rev 8(2), 87–93.
Fazzari, M.J. and Greally, J.M. (2004) Epigenomics: Beyond CpG islands, Nat Rev Genet 5, 446–455.
Issa, J.P. (2004) CpG island methylator phenotype in cancer, Nat Rev Cancer 4, 988–993.
Vaissière, T., Sawan, C., and Herceg, Z. (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing, Mutat Res 659(1–2), 40–48.
Bell, A.C. and Felsenfeld, G. (2000) Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene, Nature 405(6785), 482–485.
Laird, P.W. (1997) Oncogenic mechanisms mediated by DNA methylation, Mol Med Today 3, 223–229.
Ladd-Acosta, C.P., Sabunciyan, S., Yolken, R.H., Webster, M.J., Dinkins, T., Callinan, P.A., Fan, J.B., Potash, J.B., and Feinberg, A.P. (2007) DNA methylation signatures within the human brain, Am J Hum Genet 81(6), 1304–1315.
Richardson, B.C. (2002) Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 132, 2401S–2405S.
Richardson, B.C. (2003) Impact of aging on DNA methylation, Ageing Res Rev 2/3, 245–261.
Weinhold, R. (2006) Epigenetics: the science of change, Environ Health Persp 114, A160–A167.
Hastie, T., Tibshirani, R., and Friedman, J.H. (2001) The Elements of Statistical Learning, Springer–Verlag, New York.
Herman, J.G. and Baylin, S.B., (2003) Gene silencing in cancer in association with promoter hypermethylation, NEJM 349, 2042–2054.
Bird, A.P. (1980) DNA methylation and the frequency of CpG in animal DNA, Nucleic Acids Res 8, 1499–1504.
Bird, A.P. (1986) CpG rich islands and the function of DNA methylation, Nature 321, 209–213.
Gardiner-Garden, M. and Frommer, M. (1987) CpG islands in vertebrate genomes, J Mol Biol 196(2), 261–282.
Heard, E. (2004) Recent advances in X-chromosome inactivation, Curr Opin Cell Biol 16, 247–255.
Yan, P.S., Efferth, T., Chen, H.L., Lin, J., Rödel, F., Fuzesi, L., and Huang, T.H. (2002) Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation, Methods 27, 162–169.
van Rijnsoever, M., Grieu, F., Elsaleh, H., Joseph, D., and Iacopetta, B. (2002) Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands, Gut 51, 797–802.
Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer, Nat Rev Genet 3, 415–428.
Gama-Sosa, M.A., Slagel, V.A., Trewyn, R.W., Oxenhandler, R., Kuo, K.C., Gehrke, C.W., and Ehrlich, M. (1983) The 5-methylcytosine content of DNA from human tumors, Nucleic Acids Res 11, 6883–6894.
Feinberg, A.P., Gehrke, C.W., Kuo, K.C., and Ehrlich, M. (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia, Cancer Res 48,1159–1161.
Ogino, S., Nosho, K., Kirkner, G.J., Kawasaki, T., Chan, A.T., Schernhammer, E.S., Giovannucci, E.L., and Fuchs, C.S. (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer, J Natl Cancer Inst 100, 1734–1738.
Feinberg, A.P., Ohlsson, R., and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer, Nat Rev Genet 7, 21–33.
Schumacher, A., Kapranov, P., Kaminsky, Z., Flanagan, J., Assadzadeh, A., Yau, P., Virtanen, C., Winegarden, N., Cheng, J., Gingeras, T., and Petronis, A. (2006) Microarray based DNA methylation profiling: technology and applications, Nucleic Acids Res 34(2), 528–542.
Beck, S. and Rakyan, V.K. (2008) The methylome: approaches for global DNA methylation profiling, Trends Genet 24(5), 231–237.
Zilberman, D. and Henikoff, S. (2007) Genome-wide analysis of DNA methylation patterns, Development 134, 3959–3965.
Dupont, J.M., Tost, J., Jammes, H., and Gut, I.G. (2004) De novo quantitative bisulfite sequencing using the pyrosequencing technology, Anal Biochem 333, 119–127.
Eads, C.A., Danenberg, K.D., Kawakami, K., Saltz, L.B., Blake, C., Shibata, D., Danenberg, P.V., and Laird, P.W. (2000) MethyLight: A high-throughput assay to measure DNA methylation, 28, E32.
Weber, M., Davies, J.J., Wittig, D., Oakeley, E.J., Haase, M., Lam, W.L., and Schubeler, D. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells, Nat Genet 37, 853–862.
Khulan, B., Thompson, R.F., Ye, K., Fazzari, M.J., Suzuki, M., Stasiek, E., Figueroa, M.E., Glass, J.L., Chen, Q., Montagna, C., Hatchwell, E., Selzer, R.R., Richmond, T.A., Green, R.D., Melnick, A., and Greally, J.M. (2006) Comparative isoschizomer profiling of cytosine methylation: the HELP assay, Genome Res 16, 1046–1055.
Sutherland, E., Coe, L., and Raleigh, E.A. (1992) McrBC: a multisubunit GTP-dependent restriction endonuclease, J Mol Biol 225, 327–348.
Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. (1994) High sensitivity mapping of methylated cytosines, Nucleic Acids Res 22, 2990–2997.
Clark, S.J., Statham, A., Stirzaker, C., Molloy, P.L., and Frommer, M. (2006) DNA methylation: bisulphite modification and analysis, Nat Protoc 1, 2353–2364.
Bibikova, M., Lin, Z., Zhou, L., Chudin, E., Garcia, E.W., Wu, B., Doucet, D., Thomas, N.J., Wang, Y., Vollmer, E., Goldmann, T., Seifart, C., Jiang, W., Barker, D.L., Chee, M.S., Floros, J., and Fan, J. (2006b) High-throughput DNA methylation profiling using universal bead arrays, Genome Res 16, 383–393.
Frommer, M., McDonald, L.E., Millar, D.S., Collis, C.M., Watt, F., Grigg, G.W., Molloy, P.L., and Paul, C.L. (1982) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands, Proc Natl Acad Sci USA 89(5), 1827–1831.
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V.K., Attwood, J., Burger, M., Burton, J., Cox, T.V., Davies, R., Down, T.A., Haefliger, C., Horton, R., Howe, K., Jackson, D.K., Kunde, J., Koenig, C., Liddle, J., Niblett, D., Otto, T., Pettett, R., Seemann, S., Thompson, C., West, T., Rogers, J., Olek, A., Berlin, K., and Beck, S. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22, Nat Genet 38, 1378–1385.
Ehrich, M., Turner, J., Gibbs, P., Lipton, L., Giovanneti, M., Cantor, C., and van den Boom, D. (2008) Cytosine methylation profiling of cancer cell lines, Proc Natl Acad Sci USA 105(12), 4844–4849.
Jeddeloh, J.A., Greally, J.M., and Rando, O.J. (2008) Reduced-representation methylation mapping, Genome Biol 9(8), 231.
Down, T.A., Rakyan, V.K., Turner, D.J., Flicek, P., Li, H., Kulesha, E., Gräf, S., Johnson, N., Herrero, J., Tomazou, E.M., Thorne, N.P., Bäckdahl, L., Herberth, M., Howe, K.L., Jackson, D.K., Miretti, M.M., Marioni, J.C., Birney, E., Hubbard, T.J., Durbin, R., Tavaré, S., and Beck, S. (2008) A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis, Nat Biotech 27(7), 779–785.
Irizarry, R., Ladd-Acosta, C., Carvalho, B., Wu, H., Brandenburg, S.A., Jeddeloh, J.A., Wen, B., and Feinberg, A.P. (2008) Comprehensive high-throughput arrays for relative methylation (CHARM), Genome Res 18, 780–790.
Taylor, K.H., Kramer, R.S., Davis, W.J., Guo J., Du, D.J., Xu, D., Caldwell, C.W., and Shi, H. (2007) Ultradeep bisulphite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing, Cancer Res 67(18), 8511–8518.
Candiloro, I.L., Mikeska, T., Hokland, P., and Dobrovic, A. (2008) Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene, Epigenet Chromatin 31(1), 7–15.
Thompson, R.F., Reimers, M., Khulan, B., Gissot, M., Richmond, T.A., Chen, Q., Zheng, X., Kim, K., and Greally, J.M. (2008) An analytical pipeline for genomic representations used for cytosine methylation studies, Bioinformatics 24(9), 1161–1167.
Pelizzola, M., Koga, Y., Urban, A.E., Krauthammer, M., Weissman, S., Halaban, R., and Molinaro, A.M. (2008) MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment, Genome Res 18(10), 1652–1659.
Irizarry, R.A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., Ji, H., Potash, J.B., Sabunciyan, S., and Feinberg, A.P. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores, Nat Genet 41(2), 178–86.
Brock, M.V., Hooker, C.M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glöckner, S., Piantadosi, S., Gabrielson, E., Pridham, G., Pelosky, K., Belinsky, S.A., Yang, S.C., Baylin, S.B., and Herman, J.G. (2008) DNA methylation markers and early recurrence in stage I lung cancer, N Engl J Med 358, 1118–1128.
Tsou, J.A., Hagen, J.A., Carpenter, C.L., and Laird-Offringa, I.A. (2002) DNA methylation analysis: a powerful new tool for lung cancer diagnosis, Oncogene 21, 5450–5461.
Siegmund, K.D., Connor, C.M., Campan, M., Tiffany, L.I., Weisenberger, D.J., Biniszkiewicz, D., Jaenisch, R., Laird, P.W., and Akbarian, S. (2007) DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons, PLOS ONE 2(9), e895.
Siegmund, K.D. and Laird, P.W. (2002) Analysis of complex methylation data, Methods 27, 170–178.
Efron, B. and Tibshirani, R.J. (1994) An Introduction to the Bootstrap. Chapman & Hall, London.
Herman, J.G. (1999) Hypermethylation of tumor suppressor genes in cancer, Semin Cancer Biol 9, 359–367.
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J.G., Baylin, S.B., and Issa, J.P. (1999) CpG island methylator phenotype in colorectal cancer, Proc Natl Acad Sci USA 96, 8681–8686.
Li, Q., Jedlicka, A., Ahuja, N., Gibbons, M.C., Baylin, S.B., Burger, P.C., and Issa, J.P. (1998) Concordant methylation of the ER and N33 genes in glioblastoma multiforme, Oncogene 16, 3197–3202.
Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S.B., and Issa, J.P. (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype, Cancer Res 59, 5438–5442.
Kim, H., Kim, Y.H., Kim, S.E., Kim, N.G., Noh, S.H., and Kim, H. (2003) Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability, J Pathol 200, 23–31.
Ueki, T., Toyota, M., Sohn, T., Yeo, C.J., Issa, J.P., Hruban, R.H., Goggins, M. (2000) Hypermethylation of multiple genes in pancreatic adenocarcinoma, Cancer Res 60, 1835–1839.
Strathdee, G., Appleton, K., Illand, M., Millan, D.W., Sargent, J., Paul, J., and Brown, R. (2001) Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes, Am J Pathol 158, 1121–1127.
Garcia-Manero, G., Daniel, J., Smith, T.L., Kornblau, S.M., Lee, M., Kantarjian, H.M., and Issa, P.J. (2002) DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia, Clin Cancer Res 8, 2217–2224.
Toyota, M. and Issa, J.P. (1999) CpG island methylator phenotypes in aging and cancer, Semin Cancer Biol 9(5), 349–357.
Toyota, M., Ohe-Toyota, M., Ahuja, N., and Issa, J.P. (2000) Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype, Proc Natl Acad Sci USA 97, 710–715.
Storey, J.D. and Tibshirani, R. (2003) Statistical significance for genomewide studies, Proc Natl Acad Sci USA 100, 9440–9445.
Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc Ser B 57, 289–300.
Holm, S. (1979) A simple sequentially rejective multiple test procedure, Scand J Stat 6, 65–70.
Wacholder, S., Chanock, S., Garcia-Closas, M., El-Ghormli, L., and Rothman, N. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies, J Natl Cancer Inst 96, 434–442.
Wakefield, J. (2008) Reporting and interpretation in genome-wide association studies, Int J Epidemiol 37, 641–653.
Dudoit, S., Fridlyand, J., and Speed, T.P. (2000) Comparison of discrimination methods for the classification of tumors using gene expression data, Department of Statistics, University of California, Berkeley, CA, Tech Rep 576.
Hand, D.J. (2008) Breast cancer diagnosis from protein mass spectrometry data: a comparative evaluation, Stat Appl Genet Mol Biol 7(2), 15, 1–21.
Molinaro, A.M., Simon, R., and Pfeiffer, R.M. (2005) Prediction error estimation: a comparison of resampling methods, Bioinformatics 21(15), 3301–3307.
Miller, A. (2002) Subset Selection in Regression. Chapman & Hall/CRC, London.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Fazzari, M.J., Greally, J.M. (2010). Introduction to Epigenomics and Epigenome-Wide Analysis. In: Bang, H., Zhou, X., van Epps, H., Mazumdar, M. (eds) Statistical Methods in Molecular Biology. Methods in Molecular Biology, vol 620. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-580-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-60761-580-4_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-578-1
Online ISBN: 978-1-60761-580-4
eBook Packages: Springer Protocols